Hanmi Signs Exclusive Partnership with New Mexican Partner Laboratorios Sanfer, Covering Efpeglenatide and Diabetes Treatments SEOUL, South Korea, Jan. 27, 2026 /PRNewswire/ -- Hanmi is accelerating its global market entry with efpeglenatide, Korea's first domestically developed GLP-1...
Hence then, the article about hanmi secures export deal with mexican partner sanfer for glp 1 obesity drug and more was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Hanmi Secures Export Deal with Mexican Partner Sanfer for GLP-1 Obesity Drug and More )
Also on site :
- Decorated local aviator details his pursuit of recognition for his fellow shadow warriors of the Cold War
- Karol G Stunned by Surprise AMAs Win After Accepting International Artist of Excellence: ‘My Life Is Meaningful Because of My Music’
- Summer Reading Recommendations: Anticipated Summer Book Releases of 2026